Medical Device Outsourcing Market, By Type (By Product (Raw Materials, Electronics, and Finished Goods), By Device Type (Class I, II, and III Devices)), By Application (Orthopedic & Spine, Cardiovascular, Radiology, and General Medical Devices), By Service (Prototype Development, Finished Device Manufacturing, Assembly & Packaging, and Testing & Regulatory Support Services) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Medical Device Outsourcing Market was valued at US$ 129 billion in 2024 and is projected to grow at a CAGR of 12.9% to reach US$ 390.9 billion by 2034.

Medical device outsourcing refers to the outsourced manufacture of medical devices. Medical device firms can use outsourcing to execute recurrent production and benefit from cost savings, a streamlined supply chain, and logistical alignment. All of these features enable them deliver commercial goods to market while meeting all industry requirements. The medical device component outsourced to contract manufacturers and service providers includes design consultation, device assembly and packaging for shipment, manufacturing process designing and package testing validation service, process improvement identification, recurring processing services, and sterilization validation. Medical device outsourcing is a supply chain management phenomena that focuses on contracting with a third party for product design, production, packaging, testing, prototyping, and verification of medical equipment in a sterile and regulated environment. Typically, outsourcing entails a contract between the client company and the supplier or external outsourced service provider. The provider assumes control of the client's production assets, personnel, and extra resources under the conditions of the contract. Furthermore, the client firm receives services from the supplier in accordance with the contract terms.

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Large increase in the elderly population

During the forecast period, the market is likely to be driven by rising demand for medical devices, rising pricing competition, and the need to cut costs. Furthermore, rising product engineering challenges, as well as an increasing number of new entrants, are expected to shape the market's future. The COVID-19 pandemic had resulted in a high demand for RT-PCR and COVID-19 antigen test kits. The ongoing pandemic will almost certainly benefit the market. The rising frequency of chronic diseases is driving demand for medical gadgets. Over the forecast period, the increased frequency of chronic diseases such as cancer is expected to drive the expansion of the worldwide medical devices outsourcing market. Cancer has become much more common in the last few decades. According to the International Agency for Research on Cancer, approximately one in every five persons develop cancer during their lifetime, and one in every eight men and one in every eleven women die from the disease. Lip, oral cavity, lung, stomach, colorectal, and esophageal cancers are the most prevalent in men, whereas breast, lip, oral cavity, cervix, lung, and gastric cancers are the most common in women. Another important factor driving market expansion is the growing geriatric population and their vulnerability to diseases.

The Global Medical Device Outsourcing Market report segments the market on the basis of type, application, service and region.

On the basis of Type, the Global Medical Device Outsourcing Market is segmented into Product (Raw Materials, Electronics, and Finished Goods), Device Type (Class I, II, and III Devices). Based on Application, the market is segmented into Orthopedic & Spine, Cardiovascular, Radiology, and General Medical Devices. Based on Service, the market is segmented into Prototype Development, Finished Device Manufacturing, Assembly & Packaging, and Testing & Regulatory Support Services.

Regional Insights:

Medical Device Outsourcing Market accounted for US$ 50.11 billion in 2020 and is estimated to be US$ 134.89 billion by 2030 and is anticipated to register a CAGR of 11.50%.On region the Global Medical Device Outsourcing Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific region has outperformed in terms of growth, owing mostly to significant countries such as India and China, among others. Due to large population bases, rising demand for single-use medical devices, ongoing innovations and technological breakthroughs in the medical device industry, and rising chronic diseases, emerging countries have made significant contributions to market growth. Furthermore, Asia Pacific countries have become appealing outsourcing hubs for medical device manufacturers due to low operating and labour costs, a large talent pool, and the existence of various clinical trial locations.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the Medical Device Outsourcing Market report based on Type, Application, Service and region

Global Medical Device Outsourcing Market, By Region:

• North America
  • Middle East & Africa
    • • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • • U.S.
    • Canada

The key players operating in the Medical Device Outsourcing Market includes SGS SA, Intertek Group PLC, Wuxi Apptec, TüvSüd AG, Toxikon, INC., American Preclinical Services, Eurofins Scientific, Sterigenics International LLC, Pace Analytical Services LLC., Charles River Laboratories International, Inc., North American Science Associates, Inc., IQVIA, Accellent Inc., Celestica Inc., Benchmark Electronic Inc., Cadence Inc., Providien LLC, Thermo Fischer Scientific Inc., and West Pharmaceuticals Services Inc.

Medtronic:

Medtronic plc is a registered American-Irish medical device business based in the United States. Medtronic's operational and executive headquarters are located in Minneapolis, Minnesota, in the United States.

• SGS SA
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Intertek Group PLC
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Wuxi Apptec
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• TüvSüd AG
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Toxikon
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• American Preclinical Services
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Eurofins Scientific
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Sterigenics International LLC
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies